Expand GUTS Menu
GUTS MENU

GUTS Latest Press Releases

-- June 4, 2026 --

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita Procedure Globe Newswire 7:00 AM

-- June 1, 2026 --

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy Globe Newswire 7:00 AM

-- May 12, 2026 --

Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates Globe Newswire 4:05 PM

-- May 11, 2026 --

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes Globe Newswire 7:00 AM

-- May 5, 2026 --

Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference Globe Newswire 7:00 AM

-- March 24, 2026 --

Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates Globe Newswire 4:01 PM

-- March 17, 2026 --

Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 Globe Newswire 7:00 AM

-- February 26, 2026 --

Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita for Post-GLP-1 Weight Maintenance Globe Newswire 7:00 AM

-- January 29, 2026 --

Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - GUTS Business Wire 4:16 PM
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita After GLP-1 Discontinuation Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes